A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.
Phase 1 Recruiting
14 enrolled
Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)
Phase 1 Terminated
47 enrolled 43 charts
A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC
Phase 1/2 Recruiting
196 enrolled
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Phase 1/2 Recruiting
242 enrolled
Study to Evaluate the Safety, Tolerate, Pharmacokinetics and Preliminary Efficacy of CYH33
Phase 1 Completed
206 enrolled
An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
Phase 3 Recruiting
245 enrolled
A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors
Phase 1/2 Completed
53 enrolled
Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency
Phase 2 Completed
81 enrolled
Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)
Phase 1 Completed
168 enrolled 59 charts
METEOR
Phase 3 Completed
658 enrolled 15 charts
COMPLEMENT 1
Phase 3 Terminated
447 enrolled 32 charts
Determination of the Relative Bioavailability of ARQ 197 Tablet Formulation With Capsule C Formulation as a Reference in Subjects With Advanced Solid Tumors
Phase 1 Completed
24 enrolled
A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet
Phase 1 Withdrawn
A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers
Phase 2 Completed
20 enrolled 27 charts
PANORAMA-5
Phase 2 Withdrawn
Ipatasertib (GDC-0068) Study to Evaluate Formulation Change and Food Effect on Bioavailability in Healthy Subjects
Phase 1 Completed
18 enrolled
Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006)
Phase 1 Completed
158 enrolled 17 charts
Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers
Phase 1 Completed
50 enrolled
A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia
Phase 2 Completed
10 enrolled 52 charts
A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia
Phase 2 Completed
5 enrolled 23 charts
Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions
Phase 1 Completed
70 enrolled
Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer
Phase 2 Completed
Study of Talabostat in Advanced Melanoma
Phase 2 Completed